Core Viewpoint - The establishment of a standard system is crucial for the internationalization of traditional Chinese medicine (TCM), providing a pathway for core products to enter overseas markets and allowing Shouxiangu to find a differentiated breakthrough in the internationalization process [1] Group 1: International Standardization - Shouxiangu has led and participated in the formulation of over 100 TCM-related standards, including 8 international standards, with 5 already published [1] - The company initiated the ISO international standardization work for TCM products like Ganoderma and Dendrobium in 2011, facing initial challenges in the proposal process, which took several years to gain approval [2] - The ISO standards for Ganoderma and Dendrobium were officially published between 2018 and 2019 and are now applied in 31 countries and regions, including the US, Canada, Australia, and Germany [2] - The ISO standard for broken-wall Ganoderma spore powder, set to be implemented by July 2025, fills a global gap in quality specifications [2] Group 2: Quality Control and Research - The inclusion of Ganoderma acid A as a core quality evaluation index reflects the differentiation of raw materials and the transformation of quality characteristics into internationally recognized technical language [3] - Shouxiangu emphasizes a technology-driven approach across the entire industry chain, ensuring product safety, effectiveness, and stability through a standardized system [3] - The company has developed 12 new varieties of medicinal materials and holds multiple invention patents for its purification technology [3] Group 3: Financial Performance and R&D - In the first three quarters of 2025, Shouxiangu's R&D expense ratio reached 9.79%, an increase of 3.15 percentage points year-on-year, with R&D personnel accounting for 16.1% of the total workforce [4] - The project "Key Technology Innovation and Application of the Whole Industry Chain of Edible and Medicinal Fungi," co-led by Shouxiangu, won the National Science and Technology Progress Award [4] Group 4: Market Strategy and Product Development - In Q3 2025, Shouxiangu achieved revenue of 130 million yuan, a year-on-year increase of 8.51%, with online channel revenue growing by 11.80% [4] - The company is expanding its product line and targeting younger consumers by launching new products like "Dendrobium Pomelo Juice" and various snacks, which are positioned as everyday consumer goods [5][6] - The focus on younger demographics is evident in the design and pricing of new products, which aim to attract urban consumers seeking "light health" solutions [6]
寿仙谷:以标准话语权叩开中医药国际化之门